ILL joins two new European research projects
22 Mai 2026Two new European collaborative projects involving the ILL officially started on 1 May 2026.
COORDINA-INNOV: Strengthening coordination for joint technology development in Research Infrastructures
COORDINA-INNOV aims to strengthen strategic coordination and innovation across European Research Infrastructures (RIs), Technology Infrastructures, Research and Technological Organisations, and industry.
The project will lay the foundations for a European Co-Innovation Ecosystem connecting RI communities, Technology Infrastructures, funders, industry and SMEs. Building on the Horizon 2020 INFRAINNOV-04-2020 physical sciences communities and complemented by life sciences partners, COORDINA-INNOV will establish mechanisms supporting joint technology development, including a taxonomy of RI technologies, shared technology roadmaps, governance models, roadmap-based funding strategies and coordination tools.
In its first phase, the project will foster collaboration in areas such as:
- Advanced detectors and sensors
- Sustainable accelerator components
- Novel optics
- Superconducting technologies
- Robotics and AI-assisted tools
- Data platforms
Through this structured approach, COORDINA-INNOV aims to improve collaboration across research and technology communities, strengthen engagement with industry, and foster a sustainable European co-innovation ecosystem.
Aligned with the INFRA DEV 05 Area 3 call, the project builds on four pilot communities - LEAPS, AIDAinnova, TIARA and EMBL - while also involving neutron facilities such as ILL and ESS, as well as ESFRI domains. Bringing together 11 partners from 8 European Member States, COORDINA-INNOV aims to strengthen alignment between research infrastructures and industry stakeholders and support Europe’s technological competitiveness.
PRISMAP+: Furthering the European Medical Radionuclide Programme
PRISMAP+ will build on the success of PRISMAP to further strengthen Europe’s capacity to provide novel medical radionuclides for biomedical research. Planned for 2026 - 2029, the project brings together 23 beneficiary and associate institutes to coordinate access for biomedical researchers to leading European facilities through the radionuclides.eu platform.
The project focuses on overcoming technical and infrastructure barriers that limit the development of emerging radionuclides for nuclear medicine, theranostics and targeted alpha therapies. PRISMAP+ integrates a distributed European network of:
- Intense neutron sources
- Proton, deuteron and alpha accelerators
- Mass separation facilities
- Radiochemistry and radiopharmaceutical platforms
- Biomedical research hubs
The consortium will provide access to an evolving portfolio of 27 radionuclides while supporting work on isotope enrichment, radionuclide generators, target development, radiopharmaceutical standardisation and clinical translation pathways.
ILL contributes to PRISMAP+ as part of the European network of intense neutron sources supporting radionuclide production and related research activities. Within the project, ILL is involved in developing production methods for emerging noble metal radionuclides with potential applications in nuclear medicine and radiopharmaceutical research.
Funded by the European Union. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.